Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From RELAXIS
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Regulatory Briefs: Consensus Standards; Penalty Amounts Increase; Biologics Center Seeks Branch Chief
FDA adds 53 entries to the list of standards it will recognize for device pre-market submissions, and grants de novo approval for two device types. Civil money penalty amounts increase on inflation adjustment. The Center for Biologics Evaluation and Research searches for a review branch chief. More regulatory news.
- Medical Devices